Cardiometabolic risk reduction through lifestyle intervention programs in the Brazilian public health system

Diabetology & Metabolic Syndrome

Sandra RG Ferreira¹  Tainá Carvalho dos Santos¹  Emanuel Péricles Salvador¹  Camila Risso de Barros¹  Adriana Cezaretto¹  Antonela Siqueira-Catania¹ 

[1] Nutrition Department, School of Public Health, University of São Paulo, Sao Paulo, SP, Brazil

关键词: Public health system;    Cardiometabolic risk;    Metabolic syndrome;    Pre-diabetes;    Lifestyle intervention;   

Others  :  813964
DOI  :  10.1186/1758-5996-5-21

 received in 2012-09-11, accepted in 2013-03-19,  发布年份 2013

【 摘 要 】

Public health strategies to reduce cardiovascular morbidity and mortality should focus on global cardiometabolic risk reduction. The efficacy of lifestyle changes to prevent type 2 diabetes have been demonstrated, but low-cost interventions to reduce cardiometabolic risk in Latin-America have been rarely reported. Our group developed 2 programs to promote health of high-risk individuals attending a primary care center in Brazil. This study compared the effects of two 9-month lifestyle interventions, one based on medical consultations (traditional) and another with 13 multi-professional group sessions in addition to the medical consultations (intensive) on cardiometabolic parameters. Adults were eligible if they had pre-diabetes (according to the American Diabetes Association) and/or metabolic syndrome (International Diabetes Federation criteria for Latin-America). Data were expressed as means and standard deviations or percentages and compared between groups or testing visits. A p-value < 0.05 was considered significant. Results: 180 individuals agreed to participate (35.0% men, mean age 54.7 ± 12.3 years, 86.1% overweight or obese). 83 were allocated to the traditional and 97 to the intensive program. Both interventions reduced body mass index, waist circumference and tumor necrosis factor-α. Only intensive program reduced 2-hour plasma glucose and blood pressure and increased adiponectin values, but HDL-cholesterol increased only in the traditional. Also, responses to programs were better in intensive compared to traditional program in terms of blood pressure and adiponectin improvements. No new case of diabetes in intensive but 3 cases and one myocardial infarction in traditional program were detected. Both programs induced metabolic improvement in the short-term, but if better results in the intensive are due to higher awareness about risk and self-motivation deserves further investigation. In conclusion, these low-cost interventions are able to minimize cardiometabolic risk factors involved in the progression to type 2 diabetes and/or cardiovascular disease.

【 授权许可】

   
2013 Siqueira-Catania et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Morbidity and mortality: 2012 Chart Book on Cardiovascular, lung and Blood Deseases. http://www.nhlbi.nih.gov/resources/docs/2012_ChartBook.pdf webcite
• [2]Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
• [3]Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
• [4]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, for the Diabetes Prevention Program Research Group, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
• [5]Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP): The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289-297.
• [6]Alberti KG, Zimmet P, Shaw J: International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med 2007, 24:451-463.
• [7]Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, Foulkes MA, Zhang P, Saudek CD, Brown MB, for the Diabetes Prevention Program Research Group: The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012, 35:723-730.
• [8]Lindström J, Parikka PL, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, on behalf of the Finnish Diabetes Prevention Study Group: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet 2006, 368:1673-1679.
• [9]Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, Touboul PJ, Boissonnet CP, Escobedo J, Pellegrini F, Macchia A, Wilson E, CARMELA Study Investigators: CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008, 121:58-65.
• [10]Siqueira AFA, Cezaretto A, Barros CR, Salvador EP, Ferreira SRG: Descrição dos encontros psicoeducativos em grupo aplicados na intervenção interdisciplinar do piloto do PDM. http://hygeia.fsp.usp.br/prevsm/manual.pdf webcite
• [11]Schernthaner GH, Schernthaner G: Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention. Scand J Clin Lab Invest 2005, 65(Suppl 240):30-40.
• [12]WHO: WHO STEPwise approach to surveillance (STEPS). Geneva: World Health Organization (WHO); 2008b.
• [13]Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al.: International physical activity questionnaire: 12-country reliability and validity. Medicine and Science Sports and Exercise 2003, 35:1381-1395.
• [14]American Diabetes Association: Standards of medical care in diabetes - 2008. Diabetes Care 2008, 31(Suppl 1):12-14.
• [15]Alberti KG, Zimmet P, Shaw J: Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006, 23:469-480.
• [16]Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-419.
• [17]De-Plan. http://ec.europa.eu/health/ph_projects/2004/action3/docs/2004_3_25_inter_en.pdf webcite
• [18]Schwarz PEH, Gruhl U, Bornstein SR, Landgraf R, Hall M, Tuomilehto J: The European perspective on diabetes prevention: development and implementation of a European guideline and training standards for diabetes prevention (IMAGE). Diabetes Vasc Dis Res 2007, 4:353-357.
• [19]Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N: Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med 2012, 27:459-465.
• [20]Antuna-Puente B, Feve B, Fellahi S, Bastard JP: Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34:2-11.
• [21]Absetz P, Oldenburg B, Hankonen N, Valve R, Heinoneh H, Nissinen A, Fogelholm M, Talja M, Uutela A: Type 2 diabetes prevention in the real world. Three-year results of the GOAL lifestyle implementation trial. Diabetes Care 2009, 32:1418-1420.
• [22]Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control. A meta-analytic review of the literature. Diabetes Care 2000, 23:934-942.
• [23]Cezaretto A, Siqueira-Catania A, Barros CR, Salvador EP, Ferreira SRG: Benefits on quality of life concomitant to metabolic improvement in intervention program for prevention of diabetes mellitus. Qual Life Res 2012, 21:105-113.